eFFECTOR Therapeutics Inc

eFFECTOR Therapeutics Inc financial statements

eFFECTOR Therapeutics Inc's income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2023

RevenueUSD 0EODHD
Net income−USD 35.81MEODHD
Cash and equivalentsUSD 14.88MEODHD
Total debtUSD 20.55MEODHD

eFFECTOR Therapeutics Inc financials on 6ix · eFFECTOR Therapeutics Inc on 6ix